Banc of America Downgrades Cytyc
Cytyc (CYTC ) shares fell after it announced that the Federal Trade Commission will block the acquisition of Digene. The company sees lower than expected EPS of break-even to $0.03 (pro forma).
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.